CytotoxicHormoneReceptorStatusGeneticPredispositionAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerHerceptinGermlineMutationPhysicalactivity mayreduce therisk of breastcancersECOGScore1 in 8womenCMFChemotherapyHormoneReplacementTherapyIn-situCarcinomaImmunotherapyAntibodyTherapyRADNeoadjuvantTherapyMultimodalityTherapyDoxorubicinRaloxifenePathologicResponseBreastCancerWomen ages40+ shouldhave a clinicalbreast examat least yearlyFlowCytometryGailModelCalcificationsBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55BrachytherapyEGFRMastectomyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltGeneMutationBI-RADSStagingBilateralProphylacticMastectomyHER-2MetastasisAlopeciaDown-StagingOvarianSuppressionACChemotherapyLumpAntiemeticsLCISGuaranteedRenewableInsuranceTamoxifenGeneticCounselingMegestrolAcetateEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearOligometastasesPhyllodesTumorER+/-FibroadenomaDefinitiveSurgeryLymphNodeStatusCytostaticFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.Triple +/-BreastCancerCo-survivorDocetaxelFISHAdenocarcinomaSelf-examinationKi-67RateBiopsyLymphoscintigraphyPARPInhibitorsMRIMastodyniamTORInhibitorsFamilyHistoryCystProgestinAromataseInhibitorsPaclitaxelBreastTomosynthesisPalpationPrecisionMedicineAnastrozoleApoptosisTyrosine-KinaseInhibitorChemopreventionBRCAGeneRelapseEstrogen/EstradiolCyclophosphamideMethotrexate5-FluorouracilChemotherapyWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.AbsoluteRiskPagetDiseaseSERMAyurvedaCheckpointInhibitorAdjuvantTherapyCachexiaMorpheaLumpectomyPI3KinaseInhibitorsDimplingPalbociclibDoseDenseTherapyLapatinibAdvocacyIntraductalPapillomaRadiotherapyCAMBOCAAngiogenesisCDK4/6InhibitorsKappaEpsilonMultifocalTumorsBevacizumabTumorGradeCapecitabineAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCytotoxicHormoneReceptorStatusGeneticPredispositionAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerHerceptinGermlineMutationPhysicalactivity mayreduce therisk of breastcancersECOGScore1 in 8womenCMFChemotherapyHormoneReplacementTherapyIn-situCarcinomaImmunotherapyAntibodyTherapyRADNeoadjuvantTherapyMultimodalityTherapyDoxorubicinRaloxifenePathologicResponseBreastCancerWomen ages40+ shouldhave a clinicalbreast examat least yearlyFlowCytometryGailModelCalcificationsBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55BrachytherapyEGFRMastectomyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltGeneMutationBI-RADSStagingBilateralProphylacticMastectomyHER-2MetastasisAlopeciaDown-StagingOvarianSuppressionACChemotherapyLumpAntiemeticsLCISGuaranteedRenewableInsuranceTamoxifenGeneticCounselingMegestrolAcetateEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearOligometastasesPhyllodesTumorER+/-FibroadenomaDefinitiveSurgeryLymphNodeStatusCytostaticFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.Triple +/-BreastCancerCo-survivorDocetaxelFISHAdenocarcinomaSelf-examinationKi-67RateBiopsyLymphoscintigraphyPARPInhibitorsMRIMastodyniamTORInhibitorsFamilyHistoryCystProgestinAromataseInhibitorsPaclitaxelBreastTomosynthesisPalpationPrecisionMedicineAnastrozoleApoptosisTyrosine-KinaseInhibitorChemopreventionBRCAGeneRelapseEstrogen/EstradiolCyclophosphamideMethotrexate5-FluorouracilChemotherapyWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.AbsoluteRiskPagetDiseaseSERMAyurvedaCheckpointInhibitorAdjuvantTherapyCachexiaMorpheaLumpectomyPI3KinaseInhibitorsDimplingPalbociclibDoseDenseTherapyLapatinibAdvocacyIntraductalPapillomaRadiotherapyCAMBOCAAngiogenesisCDK4/6InhibitorsKappaEpsilonMultifocalTumorsBevacizumabTumorGradeCapecitabineAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite women

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
  1. Cytotoxic
  2. Hormone Receptor Status
  3. Genetic Predisposition
  4. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  5. Herceptin
  6. Germline Mutation
  7. Physical activity may reduce the risk of breast cancers
  8. ECOG Score
  9. 1 in 8 women
  10. CMF Chemotherapy
  11. Hormone Replacement Therapy
  12. In-situ Carcinoma
  13. Immunotherapy
  14. Antibody Therapy
  15. RAD
  16. Neoadjuvant Therapy
  17. Multimodality Therapy
  18. Doxorubicin
  19. Raloxifene
  20. Pathologic Response
  21. Breast Cancer
  22. Women ages 40+ should have a clinical breast exam at least yearly
  23. Flow Cytometry
  24. Gail Model
  25. Calcifications
  26. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  27. Brachytherapy
  28. EGFR
  29. Mastectomy
  30. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  31. Gene Mutation
  32. BI-RADS
  33. Staging
  34. Bilateral Prophylactic Mastectomy
  35. HER-2
  36. Metastasis
  37. Alopecia
  38. Down-Staging
  39. Ovarian Suppression
  40. AC Chemotherapy
  41. Lump
  42. Antiemetics
  43. LCIS
  44. Guaranteed Renewable Insurance
  45. Tamoxifen
  46. Genetic Counseling
  47. Megestrol Acetate
  48. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  49. Oligometastases
  50. Phyllodes Tumor
  51. ER +/-
  52. Fibroadenoma
  53. Definitive Surgery
  54. Lymph Node Status
  55. Cytostatic
  56. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  57. Triple +/- Breast Cancer
  58. Co-survivor
  59. Docetaxel
  60. FISH
  61. Adenocarcinoma
  62. Self-examination
  63. Ki-67 Rate
  64. Biopsy
  65. Lymphoscintigraphy
  66. PARP Inhibitors
  67. MRI
  68. Mastodynia
  69. mTOR Inhibitors
  70. Family History
  71. Cyst
  72. Progestin
  73. Aromatase Inhibitors
  74. Paclitaxel
  75. Breast Tomosynthesis
  76. Palpation
  77. Precision Medicine
  78. Anastrozole
  79. Apoptosis
  80. Tyrosine-Kinase Inhibitor
  81. Chemoprevention
  82. BRCA Gene
  83. Relapse
  84. Estrogen/Estradiol
  85. Cyclophosphamide
  86. Methotrexate
  87. 5-Fluorouracil
  88. Chemotherapy
  89. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  90. Absolute Risk
  91. Paget Disease
  92. SERM
  93. Ayurveda
  94. Checkpoint Inhibitor
  95. Adjuvant Therapy
  96. Cachexia
  97. Morphea
  98. Lumpectomy
  99. PI3 Kinase Inhibitors
  100. Dimpling
  101. Palbociclib
  102. Dose Dense Therapy
  103. Lapatinib
  104. Advocacy
  105. Intraductal Papilloma
  106. Radiotherapy
  107. CAM
  108. BOCA
  109. Angiogenesis
  110. CDK4/6 Inhibitors
  111. Kappa Epsilon
  112. Multifocal Tumors
  113. Bevacizumab
  114. Tumor Grade
  115. Capecitabine
  116. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women